189 related articles for article (PubMed ID: 11294705)
1. New technologies to prevent intravascular catheter-related bloodstream infections.
Mermel LA
Emerg Infect Dis; 2001; 7(2):197-9. PubMed ID: 11294705
[TBL] [Abstract][Full Text] [Related]
2. Prevention of intravascular catheter-related infections.
Mermel LA
Ann Intern Med; 2000 Mar; 132(5):391-402. PubMed ID: 10691590
[TBL] [Abstract][Full Text] [Related]
3. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
[TBL] [Abstract][Full Text] [Related]
4. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
Maki DG; Stolz SM; Wheeler S; Mermel LA
Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
7. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.
Marciante KD; Veenstra DL; Lipsky BA; Saint S
Am J Infect Control; 2003 Feb; 31(1):1-8. PubMed ID: 12548250
[TBL] [Abstract][Full Text] [Related]
8. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.
Lorente L; Lecuona M; Jiménez A; Santacreu R; Raja L; Gonzalez O; Mora ML
Am J Infect Control; 2014 Mar; 42(3):321-4. PubMed ID: 24581021
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
[TBL] [Abstract][Full Text] [Related]
10. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2014 Oct; 42(10):1130-2. PubMed ID: 25278411
[TBL] [Abstract][Full Text] [Related]
11. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
[TBL] [Abstract][Full Text] [Related]
12. Prevention of catheter-related infections: the skin.
Darouiche RO; Raad II
Nutrition; 1997 Apr; 13(4 Suppl):26S-29S. PubMed ID: 9178307
[TBL] [Abstract][Full Text] [Related]
13. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial.
Logghe C; Van Ossel C; D'Hoore W; Ezzedine H; Wauters G; Haxhe JJ
J Hosp Infect; 1997 Oct; 37(2):145-56. PubMed ID: 9364263
[TBL] [Abstract][Full Text] [Related]
15. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
16. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.
Raad I; Darouiche R; Dupuis J; Abi-Said D; Gabrielli A; Hachem R; Wall M; Harris R; Jones J; Buzaid A; Robertson C; Shenaq S; Curling P; Burke T; Ericsson C
Ann Intern Med; 1997 Aug; 127(4):267-74. PubMed ID: 9265425
[TBL] [Abstract][Full Text] [Related]
17. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units.
Ramritu P; Halton K; Collignon P; Cook D; Fraenkel D; Battistutta D; Whitby M; Graves N
Am J Infect Control; 2008 Mar; 36(2):104-17. PubMed ID: 18313512
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial.
Darouiche RO; Berger DH; Khardori N; Robertson CS; Wall MJ; Metzler MH; Shah S; Mansouri MD; Cerra-Stewart C; Versalovic J; Reardon MJ; Raad II
Ann Surg; 2005 Aug; 242(2):193-200. PubMed ID: 16041209
[TBL] [Abstract][Full Text] [Related]
19. Arterial catheter-related bloodstream infection: incidence, pathogenesis, risk factors and prevention.
Safdar N; O'Horo JC; Maki DG
J Hosp Infect; 2013 Nov; 85(3):189-95. PubMed ID: 24070632
[TBL] [Abstract][Full Text] [Related]
20. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
